Regarding cancer type and gender in pathogenic variants, BRCA1 was more commonly associated with breast and ovarian cancer, while BRCA2 was more widely detected in prostate cancer, pancreatic cancer, cholangiocarcinoma, and others (Table 2). Here, BRCA2 is linked to prostate cancer.